People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

New and innovative mechanisms of action are constantly being discovered and developed into medicines that tackle a broad ...

The treatment is recommended for people aged 12 to 65 who have moderate to severe and persistent allergic rhinitis and have been diagnosed through clinical history and a positive test of their house ...

What is the impact of HRT on health outcomes for trans men and non-binary people registered female at birth (who are not taking gender-affirming hormone therapy at the time of taking HRT or in the ...

For people with a personal history of breast cancer, or at high familial or genetic risk of breast cancer, does vaginal oestrogen for genitourinary symptoms associated with menopause increase the risk ...

What is the effect of either taking or not taking hormone replacement therapy (HRT) on health outcomes for people experiencing early menopause (aged 40 to 44)? For a short explanation of why the ...

For a short explanation of why the committee made this recommendation for research, see the rationale section on routine pharmacological management . Full details of the evidence and the committee's ...

In people at risk of adrenal insufficiency because of prolonged glucocorticoid use, what is the best way to manage glucocorticoid withdrawal when they are no longer needed?

For a short explanation of why the committee made this recommendation for research, see the rationale section on effects of combined HRT on specific health outcomes in people aged 45 or over Full ...

What is the clinical and cost effectiveness of postoperative glucocorticoids for people with, or at risk of, adrenal insufficiency having inpatient invasive procedures? For a short explanation of why ...